You are currently viewing a new version of our website. To view the old version click .

Antimicrobial Resistance during the COVID-19 Outbreak

This special issue belongs to the section “Antibiotic Therapy in Infectious Diseases“.

Special Issue Information

Dear Colleagues,

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent pandemic has placed an immense strain on healthcare systems worldwide. The challenges posed by the diagnosis and management of coronavirus disease 2019 (COVID-19) together with concerns regarding associated bacterial and fungal infection have promoted the extensive use of antimicrobials in acute care. In contrast, in the community, we have observed a reduction of antimicrobial use. The impact that the COVID-19 pandemic will have on antimicrobial resistance in the long term remains unknown.

We are pleased to invite you to contribute to this Special Issue of Antibiotics. The aim of this Special Issue is to provide insights into the impact of COVID-19 on antimicrobial use and antimicrobial resistance. We also aim to highlight and discuss specific interventions that have been developed to address inappropriate antimicrobial use and antimicrobial resistance during the pandemic.

Dr. Mirela Grigoraș
Prof. Dr. Cristian Oancea
Dr. Cosmin Citu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial stewardship
  • antimicrobial resistance
  • COVID-19
  • SARS-CoV-2
  • diagnostics
  • interventions
  • co-infection
  • healthcare-associated infection

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382